Mon, 05 Feb 2024 15:30:04 GMT
Bristol Myers earnings surprise markets
The pharmaceutical company Bristol Myers has surprised the markets with higher than expected quarterly sales results. The good results were attributed to the new anemia drug Reblozyl and blood cancer drug Revlimid.